Zoic Capital, an early-stage venture capital firm focused on medical technology, has added MedTech and Payer industry veteran Shayan Bhattacharyya to the team as Venture Partner.
Shayan has deep expertise across the healthcare ecosystem and works with MedTech startups from design to commercialization. He brings a depth of experience from large payer organizations, which will challenge the organization to think deeply about how data-driven insight can impact a value-based healthcare world. At Zoic, he will advise and mentor the firm’s portfolio companies and support our diligence process for potential investments.
“Shayan comes to us at a time and with a background that we believe can help us better support our portfolio companies to deliver value to their end customers more effectively and efficiently,” said Zoic Managing Director Neal Mody.
“He has deep domain expertise across a broad range of therapeutic areas and customer groups, including patient, physician, and payer. We’ve appreciated his ability to recognize the competing interests at play in a situation and cut to the heart of the matter quickly and accurately– particularly competitive dynamics. He is guided by strong customer empathy, curiosity, and commercial competence driven by a relentless desire to serve patients and patient populations better than they’re served today while delivering value for healthcare systems. We are thrilled to have him aboard.”
Most recently, he has been focused on advising startups (generally, seed to Series C) on commercial and acquisition strategy at his firm Signal to Exit (www.signaltoexit.com). Previously, Shayan was General Manager for United Health Group’s digital health/ coaching diabetes prevention business. He was also head of strategy and M&A for Blue Cross Blue Shield’s data and analytics spin-out business, Blue Health Intelligence. He also spent ten years at Medtronic and Boston Scientific in various commercial leadership roles in different therapeutic areas.
“Shayan has been invaluable to us already. He is a smart and clear thinker with an incredible grasp of spoken and unspoken commercial realities. He is great to work with because he draws out collective intelligence to help his teams arrive at better decisions and give a greater likelihood of delivering value to our patients and, ultimately, our potential acquirer. I can point to clear and material impacts in how he’s supported refining our strategy,” said Zoic portfolio company Reveal Surgical CEO Christopher Kent.
When asked for comment on this milestone, Shayan said: “I am grateful most in my career for those mentors who have invested time and compassion in my development as a professional and human being. I am excited to bring to bear all my healthcare experiences, particularly building and growing new disruptive businesses, to serve this impressive group of early-stage entrepreneurs in their journey.”
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
